Francesca Saccani

527 total citations
20 papers, 445 citations indexed

About

Francesca Saccani is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francesca Saccani has authored 20 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francesca Saccani's work include Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Receptor Mechanisms and Signaling (3 papers). Francesca Saccani is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Receptor Mechanisms and Signaling (3 papers). Francesca Saccani collaborates with scholars based in Italy, United States and Netherlands. Francesca Saccani's co-authors include Elisabetta Barocelli, Simona Bertoni, Pier Giorgio Petronini, Andrea Cavazzoni, Roberta Alfieri, Andrea Ardizzoni, Marcello Tiseo, Maricla Galetti, Daniele Cretella and Silvia La Monica and has published in prestigious journals such as Gastroenterology, PLoS ONE and Molecular Cancer.

In The Last Decade

Francesca Saccani

19 papers receiving 437 citations

Peers

Francesca Saccani
Yasmine Kanaan United States
Kaoru Terai United States
Calvin Yee United States
William D. Fox United States
Jos de Man Netherlands
Quang T. Luong United States
Francesca Saccani
Citations per year, relative to Francesca Saccani Francesca Saccani (= 1×) peers Hiromi Watanabe

Countries citing papers authored by Francesca Saccani

Since Specialization
Citations

This map shows the geographic impact of Francesca Saccani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Saccani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Saccani more than expected).

Fields of papers citing papers by Francesca Saccani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Saccani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Saccani. The network helps show where Francesca Saccani may publish in the future.

Co-authorship network of co-authors of Francesca Saccani

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Saccani. A scholar is included among the top collaborators of Francesca Saccani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Saccani. Francesca Saccani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertoni, Simona, Francesca Saccani, Andrea Grandi, et al.. (2016). Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis. Frontiers in Pharmacology. 7. 68–68. 30 indexed citations
2.
Bonelli, Mara, Andrea Cavazzoni, Francesca Saccani, et al.. (2015). Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. Molecular Cancer Therapeutics. 14(8). 1916–1927. 32 indexed citations
3.
Galetti, Maricla, Pier Giorgio Petronini, Claudia Fumarola, et al.. (2015). Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines. PLoS ONE. 10(11). e0141795–e0141795. 54 indexed citations
4.
Anselmi, Laura, Jennifer Huynh, Céline Duraffourd, et al.. (2015). Activation ofμopioid receptors modulates inflammation in acute experimental colitis. Neurogastroenterology & Motility. 27(4). 509–523. 26 indexed citations
5.
Ampollini, Luca, Denise Madeddu, Angela Falco, et al.. (2014). Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†. European Journal of Cardio-Thoracic Surgery. 46(6). e103–e112. 10 indexed citations
6.
Cretella, Daniele, Francesca Saccani, Federico Quaini, et al.. (2014). Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance. Molecular Cancer. 13(1). 143–143. 55 indexed citations
7.
Bertoni, Simona, Valentina Vivo, Massimiliano Tognolini, et al.. (2014). Suppression of inflammatory events associated to intestinal ischemia–reperfusion by 5-HT1A blockade in mice. Pharmacological Research. 81. 17–25. 25 indexed citations
8.
Ampollini, Luca, Gallia Graiani, Caterina Frati, et al.. (2014). F-038 * LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS. Interactive Cardiovascular and Thoracic Surgery. 18(suppl 1). S10–S10. 1 indexed citations
9.
Galvani, Elena, Elisa Giovannetti, Francesca Saccani, et al.. (2013). Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer. Neoplasia. 15(1). 61–IN18. 13 indexed citations
10.
Monica, Silvia La, Cristina Caffarra, Francesca Saccani, et al.. (2013). Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification. PLoS ONE. 8(10). e78656–e78656. 46 indexed citations
11.
Saccani, Francesca, et al.. (2012). Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. Journal of Neuroscience Research. 90(11). 2146–2153. 27 indexed citations
12.
Cavazzoni, Andrea, Roberta Alfieri, Daniele Cretella, et al.. (2012). Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines. Molecular Cancer. 11(1). 91–91. 38 indexed citations
13.
Brullo, Chiara, Paola Fossa, Elena Cichero, et al.. (2011). Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. Bioorganic & Medicinal Chemistry Letters. 22(2). 1125–1129. 21 indexed citations
14.
Incerti, Matteo, Lisa Flammini, Francesca Saccani, et al.. (2010). Dual‐Acting Drugs: an in vitro Study of Nonimidazole Histamine H3 Receptor Antagonists Combining Anticholinesterase Activity. ChemMedChem. 5(7). 1143–1149. 23 indexed citations
15.
Gobbetti, Thomas, Simona Bertoni, Francesca Saccani, et al.. (2009). M1627 Histamine H4 Receptor Antagonism and Mesenteric Ischemia/Reperfusion Injury in Mice. Gastroenterology. 136(5). A–397. 3 indexed citations
16.
Rivara, Mirko, Silvia Rivara, Fabrizio Bordi, et al.. (2008). Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Bioorganic & Medicinal Chemistry. 16(23). 9911–9924. 27 indexed citations
17.
Bertoni, Simona, Vigilio Ballabeni, Lisa Flammini, et al.. (2008). In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(3). 335–343. 10 indexed citations
18.
Saccani, Francesca, et al.. (1969). [Separation and determination of ampicillin in combination with cloxacillin or dicloxacillin].. PubMed. 108(12). 777–80. 1 indexed citations
19.
Saccani, Francesca, et al.. (1969). [Simultaneous determination of benzylpenicillin and 6-aminopenicillanic acid in fermentation broths. 3].. PubMed. 108(5). 324–9. 1 indexed citations
20.
Saccani, Francesca, et al.. (1968). [Stability of ampicillin and hetacillin].. PubMed. 107(10). 640–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026